SuperCrowd

Impact investing news for the SuperCrowd

Sun · Aug 16, 2026 Reg CF filings Sourced from SEC EDGAR
← All filings
Amendment · Form C/A

An amendment to an offering — the company changed its terms or corrected its filing.

EmerRx Biopharma, LLC

emerrx.com · DE · Filed Feb 19, 2026

EmerRx Biopharma, LLC filed a Form C/A — amendment — with the SEC on Feb 19, 2026. The Regulation Crowdfunding offering seeks $25,000, up to a maximum of $500,000 on Microventure Marketplace .. Investors receive: Other at $1.00. The offering closes Feb 3, 2026.

Target raise$25,000
Maximum raise$500,000
SecurityOther @ $1.00
ClosesFeb 3, 2026
PortalMicroventure Marketplace .
View the official filing on SEC EDGAR →

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.